EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The utility of next‐generation sequencing in challenging liver FNA biopsies

Dana J Balitzer, Nancy Y Greenland iD

Cancer Cytopathology · 2024

DOI: 10.1002/cncy.22893 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cytopathology, 2024. Verfasst von Dana J Balitzer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of California San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Liver Neoplasms, High-Throughput Nucleotide Sequencing, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fine‐needle aspiration (FNA) biopsy is increasingly used for the diagnosis of hepatocellular masses. Because distinguishing well differentiated hepatocellular carcinoma (HCC) from other well differentiated hepatocellular lesions (e.g., large regenerative nodules or focal nodular hyperplasia) requires an assessment of architectural features, this may be challenging on FNA when intact tissue fragments are not sampled. Poorly differentiated HCC and intrahepatic cholangiocarcinoma (ICC) may exhibit overlapping pathologic features. Molecular testing can be helpful, because mutations in TERT promoter and CTNNB1 (β‐catenin) are characteristic of HCC, whereas mutations in BAP1 , IDH1/IDH2 , and PBRM1 may favor ICC. The goal of this study was to assess the role of next‐generation sequencing (NGS) in further subclassifying indeterminate liver lesions sampled by FNA.

Methods

A retrospective review of liver cytology cases with NGS on cell block material was performed. Age, radiologic features, background hepatic disease and treatment, outcome, and NGS data were obtained from the electronic medical record.

Results

Twelve FNA biopsies that had cell blocks from clinically suspected primary hepatic masses were identified. The presence of a TERT promoter mutation supported a diagnosis of HCC for one well differentiated neoplasm. For three patients, the presence of mutations, such as IDH1 , CDKN2A/CDKN2B , and BRAF , supported a diagnosis of ICC. Of the eight poorly differentiated carcinomas, NGS helped refine the diagnosis in six of eight cases, with one HCC, three ICCs, and two that had combined HCC‐ICC, with two cases remaining unclassified.

Conclusions

Molecular diagnostics can be helpful to distinguish HCC and ICC on FNA specimens, although a subset of primary hepatic tumors may remain unclassifiable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsHigh-Throughput Nucleotide SequencingCarcinoma, HepatocellularHumansBiopsy, Fine-NeedleRetrospective StudiesMaleMiddle AgedAgedFemaleMutationCholangiocarcinomaBiomarkers, TumorAdultDiagnosis, DifferentialAged, 80 and overTelomerase

Stichwörter der Autor:innen

fine‐needle aspirationhepatocellular carcinomaintrahepatic cholangiocarcinomalivernext‐generation sequencing

Substanzen

Biomarkers, TumorTERT protein, humanTelomerase

Autor:innen und Institutionen

  • Department of Pathology, University of California San Francisco, San Francisco, California, USA.

ORCID-Profile: Nancy Y Greenland

Zitieren

APA

Balitzer, D. J., & Greenland, N. Y. (2024). The utility of next‐generation sequencing in challenging liver FNA biopsies. Cancer Cytopathology. https://doi.org/10.1002/cncy.22893

Vancouver

Balitzer DJ, Greenland NY. The utility of next‐generation sequencing in challenging liver FNA biopsies. Cancer Cytopathology. 2024. doi:10.1002/cncy.22893

BibTeX
@article{Balitzer2024,
  author = {Balitzer, Dana J and Greenland, Nancy Y},
  title = {The utility of next‐generation sequencing in challenging liver FNA biopsies},
  journal = {Cancer Cytopathology},
  year = {2024},
  doi = {10.1002/cncy.22893}
}
Kostenlos starten →